Search results
‘Blue Angels’ Tests Imax’s New ‘Documentary Blockbuster’ Plan
Variety· 6 hours agoNavy’s famous flight demonstration squadron — marks the first production in what Imax senior VP and...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 5 hours agoOn the other hand, Pfizer has put that money...approved by the regulatory body last year, seven of...
Dow slams milestone 40,000 after Walmart announced blockbuster profits
Fortune· 23 minutes agoThe Dow was up 69 points, or 0.2%, at 39,967, in afternoon trading. It topped 40,000 earlier in trading, making its last leap of 10,000 points in about three and a half years, as the U.S. economy ...
Walmart Stock Jumps. Earnings Impress as Wealthier Shoppers Flock to Value.
Barrons.com· 5 hours agoWalmart stock was on track for another record high as investors rallied behind another blockbuster...
IMAX Commits to ‘Megalopolis’ Showings No Matter the Distributor
Indiewire via Yahoo News· 4 hours agoThanks to IMAX believer Chris Nolan‘s global blockbuster “Oppenheimer,” IMAX performed at peak...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks· 14 hours agoThe first-quarter earnings season has come to an end for large drug and biotech companies, with Bayer reporting its results earlier this week. Per the Zacks classification, the pharma/biotech ...
IMAX, MEGARAMA Expand Partnership for 3 New Locations in France
Zacks via Yahoo Finance· 4 hours agoThe agreement comes on the heels of a record 2023 for IMAX in France, which generated more than $23...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 4 days agoThe share of patents filed post-approval was higher for the four biologics than for the six small...
Stocks Book Weekly Gains, Extend May Rise
The Wall Street Journal· 6 days agoThe Nasdaq fell even more slightly. The Dow extended its longest winning streak of the year. The world’s biggest contract chip manufacturer, Taiwan’s...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Motley Fool via Yahoo Finance· 4 days agoThe Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The...